TrueMark Investments Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
QBER
TrueShares Quarterly Bear Hedge ETF
QBER
|
+$10.5M |
| 2 |
Blue Owl Capital
OWL
|
+$7.72M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$7.27M |
| 4 |
Clorox
CLX
|
+$6.72M |
| 5 |
Accenture
ACN
|
+$6.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$9.21M |
| 2 |
British American Tobacco
BTI
|
+$8.16M |
| 3 |
Coca-Cola
KO
|
+$5.67M |
| 4 |
Watsco Inc
WSO
|
+$5.14M |
| 5 |
Unum
UNM
|
+$5.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 13.42% |
| 2 | Financials | 13.16% |
| 3 | Technology | 9.04% |
| 4 | Healthcare | 7.9% |
| 5 | Energy | 7.87% |
Similar funds
TrueMark Investments's Q3 2025 Portfolio in Review
As of Q3 2025, TrueMark Investments held 236 positions worth $575M, up 24% from $463M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
TrueMark Investments deployed $95.1M of net new capital in Q3 2025, opening 97 new positions and adding to 63 existing holdings. Its largest new stake was Blue Owl Capital: 406,011 shares worth $6.87M.
By sector, the portfolio is most concentrated in Consumer Staples at 13% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was British American Tobacco, an estimated $8.16M trimmed.
- TrueMark Investments's largest Q3 2025 buy was Blue Owl Capital: 406,011 shares worth $6.87M.
- TrueMark Investments added most to TrueShares Quarterly Bear Hedge ETF in Q3 2025, an estimated $10.5M increase.
- TrueMark Investments's biggest Q3 2025 reduction was British American Tobacco, cutting an estimated $8.16M.
- TrueMark Investments fully exited UnitedHealth in Q3 2025, selling an estimated $9.21M.
- TrueMark Investments's ten largest holdings make up 18% of its $575M portfolio in Q3 2025.
- TrueMark Investments opened 97 new positions and closed 42 in Q3 2025.
- TrueMark Investments's portfolio value rose 24% quarter-over-quarter to $575M.
Based on TrueMark Investments's 13F filing for Q3 2025, filed 30 Oct 2025.